微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.41% | -0.87% | -74.53% | 19/69 | 2.26% | 沃华医药 | 5.94% | 行业排名> |
| 2024-12-31 | 13.39% | 0.45% | 4.94% | 10/69 | 3.28% | 天目药业 | 9.27% | 行业排名> |
| 2024-09-30 | 12.76% | -5.13% | 36.47% | 10/69 | 3.08% | 天目药业 | 22.26% | 行业排名> |
| 2024-06-30 | 9.35% | -28.52% | 171.8% | 7/69 | 0.67% | 羚锐制药 | 20.44% | 行业排名> |
| 2024-03-31 | 3.44% | -41.1% | -74.19% | 21/69 | 1.53% | 羚锐制药 | 13.25% | 行业排名> |
| 2023-12-31 | 13.33% | 75.39% | -0.89% | 13/69 | 0.11% | 片仔癀 | 7.03% | 行业排名> |
| 2023-09-30 | 13.45% | 19.03% | 2.83% | 10/69 | 7.26% | 片仔癀 | 23.1% | 行业排名> |
| 2023-06-30 | 13.08% | 32.66% | 123.97% | 3/69 | 4.93% | 太极集团 | 22.08% | 行业排名> |
| 2023-03-31 | 5.84% | 102.08% | -23.16% | 10/69 | 3.21% | 太极集团 | 17.13% | 行业排名> |
| 2022-12-31 | 7.6% | -13.14% | -32.74% | 31/69 | 6.65% | 以岭药业 | 10.43% | 行业排名> |
| 2022-09-30 | 11.3% | 14.6% | 14.6% | 13/69 | 5.16% | *ST吉药 | 72.63% | 行业排名> |
| 2022-06-30 | 9.86% | 41.67% | 241.18% | 4/69 | 3.2% | 片仔癀 | 23.54% | 行业排名> |
| 2022-03-31 | 2.89% | -11.08% | -66.97% | 27/69 | 2.18% | 片仔癀 | 19.69% | 行业排名> |
| 2021-12-31 | 8.75% | -0.23% | -11.26% | 29/69 | 4.54% | 片仔癀 | 12.75% | 行业排名> |
| 2021-09-30 | 9.86% | -6.01% | 41.67% | 21/69 | 7.54% | 片仔癀 | 6.88% | 行业排名> |
| 2021-06-30 | 6.96% | -13.11% | 114.15% | 16/69 | 4.68% | 片仔癀 | 27.39% | 行业排名> |
| 2021-03-31 | 3.25% | 20.82% | -62.94% | 18/69 | 2.7% | 片仔癀 | 23.14% | 行业排名> |
| 2020-12-31 | 8.77% | -33.46% | -16.4% | 28/69 | 0.1% | 片仔癀 | 13.23% | 行业排名> |
| 2020-09-30 | 10.49% | -11.03% | 30.96% | 16/69 | 6.79% | *ST长药 | 7.37% | 行业排名> |
| 2020-06-30 | 8.01% | -16.48% | 197.77% | 6/69 | 3.75% | 沃华医药 | 22.84% | 行业排名> |
| 2020-03-31 | 2.69% | -12.66% | -79.59% | 19/69 | 2.14% | 沃华医药 | 19.47% | 行业排名> |
| 2019-12-31 | 13.18% | -7.51% | 11.79% | 15/69 | 5.86% | 沃华医药 | 12.7% | 行业排名> |
| 2019-09-30 | 11.79% | -13.05% | 22.94% | 10/69 | 7.3% | 济川药业 | 7.33% | 行业排名> |
| 2019-06-30 | 9.59% | 1.37% | 211.36% | 5/69 | 4.72% | 济川药业 | 27.43% | 行业排名> |
| 2019-03-31 | 3.08% | -0.65% | -78.39% | 26/69 | 2.92% | 济川药业 | 23.05% | 行业排名> |
| 2018-12-31 | 14.25% | -18.43% | 5.09% | 16/69 | 7.87% | 济川药业 | 15.79% | 行业排名> |
| 2018-09-30 | 13.56% | -2.93% | 43.34% | 6/69 | 8.02% | 华润三九 | 10.23% | 行业排名> |
| 2018-06-30 | 9.46% | -5.59% | 205.16% | 3/69 | 5.03% | 济川药业 | 32.79% | 行业排名> |
| 2018-03-31 | 3.1% | 0.32% | -82.26% | 26/69 | 2.75% | 济川药业 | 27.55% | 行业排名> |
| 2017-12-31 | 17.47% | 9.05% | 25.05% | 7/69 | 9.93% | 济川药业 | 17.62% | 行业排名> |
| 2017-09-30 | 13.97% | 6.64% | 39.42% | 7/69 | 8.39% | 济川药业 | 10.07% | 行业排名> |
| 2017-06-30 | 10.02% | 9.51% | 224.27% | 3/69 | 5.24% | ST葫芦娃 | 46.01% | 行业排名> |
| 2017-03-31 | 3.09% | 2.32% | -80.71% | 26/69 | 2.62% | 济川药业 | 24.2% | 行业排名> |
| 2016-12-31 | 16.02% | 4.3% | 22.29% | 13/69 | 10.02% | *ST大药 | 15.31% | 行业排名> |
| 2016-09-30 | 13.1% | 6.5% | 43.17% | 10/69 | 9.32% | 济川药业 | 14.64% | 行业排名> |
| 2016-06-30 | 9.15% | -0.44% | 202.98% | 11/69 | 5.04% | 济川药业 | 7.64% | 行业排名> |
| 2016-03-31 | 3.02% | 39.17% | -80.34% | 26/69 | 4.1% | 维康药业 | 38.23% | 行业排名> |
| 2015-12-31 | 15.36% | -19.54% | 24.88% | 22/69 | 11.34% | 太极集团 | 58.41% | 行业排名> |
| 2015-09-30 | 12.3% | -16.27% | 33.84% | 12/69 | 8.44% | 新光药业 | 16.54% | 行业排名> |
| 2015-06-30 | 9.19% | -10.69% | 323.5% | 11/69 | 5.48% | 太极集团 | 71.6% | 行业排名> |
| 2015-03-31 | 2.17% | -32.61% | -88.63% | 36/69 | 2.9% | 维康药业 | 48.67% | 行业排名> |